Phio Pharmaceuticals Corp. (PHIO)
USD 2.57
(-9.36%)
USD 2.57
(-9.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 21 Thousand | 138 Thousand |
| Cost of Revenue | 6.33 Million | 193 Thousand | 192 Thousand | 183 Thousand | 4300.00 | 4.32 Million |
| Gross Profit | -6.33 Million | -193 Thousand | -192 Thousand | -183 Thousand | 16.7 Thousand | -4.18 Million |
| Operating Expenses | 4.49 Million | 11.46 Million | 13.51 Million | 8.79 Million | 9 Million | 7.5 Million |
| Selling, General and Administrative Expenses | 4.28 Million | 4.45 Million | 4.62 Million | 4.36 Million | 4.7 Million | 3.17 Million |
| Research and Development Expenses | 6.33 Million | 7.01 Million | 8.88 Million | 4.43 Million | 4.3 Million | 4.32 Million |
| Other Expenses | -6.12 Million | -18 Thousand | 224 Thousand | -1000.00 | 79 Thousand | 4000.00 |
| Cost and Expenses | 10.82 Million | 11.46 Million | 13.51 Million | 8.79 Million | 9 Million | 7.5 Million |
| Operating Income | -10.82 Million | -11.46 Million | -13.51 Million | -8.79 Million | -8.98 Million | -7.36 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -175 Thousand | -75 Thousand | -134.29 Thousand | -67 Thousand | 4000.00 |
| Earnings before Tax | -10.82 Million | -11.48 Million | -13.28 Million | -8.79 Million | -8.9 Million | -7.36 Million |
| Net Income | -10.82 Million | -11.3 Million | -13.21 Million | -8.79 Million | -8.84 Million | -7.36 Million |
| Earnings Per Share Basic | -46.87 | -89.61 | -111.32 | -207.25 | -2074.18 | -6218.35 |
| Earnings Per Share Diluted | -46.76 | -89.61 | -111.32 | -207.25 | -2074.18 | -6218.35 |
| Weighted Average Shares Outstanding | 231 Thousand | 126.15 Thousand | 118.68 Thousand | 42.43 Thousand | 4262.40 | 1183.59 |
| Weighted Average Shares Outstanding (Diluted) | 231.5 Thousand | 126.15 Thousand | 118.68 Thousand | 42.43 Thousand | 4262.40 | 1183.59 |
| Gross Margin | - | - | - | - | 0.80 | -30.35 |
| EBIT Margin | - | - | - | - | -427.95 | -53.36 |
| Profit Margin | - | - | - | - | -421.00 | -53.33 |
| EBITDA | -10.64 Million | -11.28 Million | -13.08 Million | -8.72 Million | -8.92 Million | -7.28 Million |
| Earnings Before Tax Margin | - | - | - | - | -427.95 | -53.36 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 30 Thousand | - | - |
| Cost of Revenue | 1000.00 | 34 Thousand | 184 Thousand | 43 Thousand | 47 Thousand | 47 Thousand |
| Gross Profit | -1000.00 | -34 Thousand | -184 Thousand | -13 Thousand | -47 Thousand | -47 Thousand |
| Operating Expenses | 1.91 Million | 2.17 Million | 10.51 Million | 1.73 Million | 2.77 Million | 2.54 Million |
| Selling, General and Administrative Expenses | 1.04 Million | 1.02 Million | - | 723 Thousand | 968 Thousand | 1.16 Million |
| Research and Development Expenses | 866 Thousand | 1.14 Million | - | 1 Million | 1.8 Million | 1.38 Million |
| Other Expenses | 68 Thousand | 55 Thousand | - | 4000.00 | -4000.00 | -2000.00 |
| Cost and Expenses | 1.91 Million | 2.2 Million | 10.69 Million | 1.77 Million | 2.77 Million | 2.54 Million |
| Operating Income | -1.91 Million | -2.2 Million | -10.69 Million | -1.77 Million | -2.78 Million | -2.54 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -9276.00 | - | 51 Thousand | -51 Thousand | -75.08 Thousand |
| Earnings before Tax | -1.84 Million | -2.15 Million | -10.82 Million | -1.89 Million | -2.78 Million | -2.54 Million |
| Net Income | -1.84 Million | -2.15 Million | -10.82 Million | -1.89 Million | -2.78 Million | -2.54 Million |
| Earnings Per Share Basic | -3.62 | -0.47 | - | -0.51 | -1.14 | -1.47 |
| Earnings Per Share Diluted | -3.62 | -0.47 | - | -0.51 | -1.14 | -1.47 |
| Weighted Average Shares Outstanding | 510.18 Thousand | 4.58 Million | 231.5 Thousand | 3.74 Million | 2.44 Million | 1.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 510.18 Thousand | 4.58 Million | 231.5 Thousand | 3.74 Million | 2.44 Million | 1.72 Million |
| Gross Margin | - | - | - | -0.43 | - | - |
| EBIT Margin | - | - | - | -57.67 | - | - |
| Profit Margin | - | - | - | -63.17 | - | - |
| EBITDA | -1.91 Million | -2.17 Million | - | -1.73 Million | -2.78 Million | -2.5 Million |
| Earnings Before Tax Margin | - | - | - | -59.10 | - | - |
2145
PNDORA
ACML
NXPL
GSC
0212